Skin cancer in transplant recipients, out of the woods. Scientific retreat of the ITSCC and SCOPE

American Journal of Transplantation

Volumn 11, Issue 8, 2011, Pages 1584-1591

  Colegio, O R ^a   Billingsley, E M ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Azathioprine; basal cell carcinoma; cancer; cyclosporine; melanoma; sirolimus; skin; skin biology; skin cancer; skin neoplasms; squamous cell carcinoma; tacrolimus; voriconazole

Indexed keywords

BASAL CELL CARCINOMA; CANCER RISK; CONFERENCE PAPER; GRAFT RECIPIENT; HUMAN; KAPOSI SARCOMA; MEDICAL SOCIETY; MELANOMA; MERKEL CELL TUMOR; ORGAN TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; SKIN CANCER;

HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; SKIN NEOPLASMS;

EID: 79961098790     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03645.x     Document Type: Conference Paper

References (33)

1. Walder BK, Robertson MR, Jeremy D,. Skin cancer and immunosuppression. Lancet 1971; 2: 1282-1283.
2. O'Donovan P, Perrett CM, Zhang X, et al,. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871-1874. (Pubitemid 41325100)
3. Hojo M, Morimoto T, Maluccio M, et al,. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397: 530-534.
4. Wu X, Nguyen BC, Dziunycz P, et al,. Opposing roles for calcineurin and ATF3 in squamous skin cancer. Nature 2010; 465: 368-372.
5. Norman KG, Canter JA, Shi M, Milne GL, Morrow JD, Sligh JE,. Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients. Mitochondrion 2010; 10: 94-101.
6. Dziunycz P, Iotzova-Weiss G, Eloranta JJ, et al,. Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation. J Invest Dermatol 2010; 130: 2686-2689.
7. Carucci JA, Martinez JC, Zeitouni NC, et al,. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: Clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004; 30 (Pt 2): 651-655. (Pubitemid 38525896)
8. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN,. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 1991; 4: 196-202.
9. Kreimer-Erlacher H, Seidl H, Back B, Kerl H, Wolf P,. High mutation frequency at Ha-ras exons 1-4 in squamous cell carcinomas from PUVA-treated psoriasis patients. Photochem Photobiol 2001; 74: 323-330.
10. Saridaki Z, Liloglou T, Zafiropoulos A, Koumantaki E, Zoras O, Spandidos DA,. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin. Br J Dermatol 2003; 148: 638-648. (Pubitemid 36629740)
11. Mortier L, Marchetti P, Delaporte E, et al,. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor. Cancer Lett 2002; 176: 205-214. (Pubitemid 34139786)
12. Bolshakov S, Walker CM, Strom SS, et al,. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas. Clin Cancer Res 2003; 9: 228-234. (Pubitemid 36109738)
13. Nelson MA, Einspahr JG, Alberts DS, et al,. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 1994; 85: 23-29. (Pubitemid 24280158)
14. Brash DE, Rudolph JA, Simon JA, et al,. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88: 10124-10128. (Pubitemid 21915787)
15. Haider AS, Peters SB, Kaporis H, et al,. Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 2006; 126: 869-881.
16. Bluth MJ, Zaba LC, Moussai D, et al,. Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation. J Invest Dermatol 2009; 129: 2451-2462.
17. Baek SK, Jung KY, Lee SH, et al,. Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma. Laryngoscope 2009; 119: 1325-1330.
18. Moussai D, Mitsui H, Pettersen JS, et al,. The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. J Invest Dermatol 2011; 131: 229-236.
19. Pettersen JS, Fuentes-Duculan J, Suarez-Farinas M, et al,. Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated. J Invest Dermatol 2011; 131: 1322-1330.
20. Salgo R, Gossmann J, Schofer H, et al,. Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: Reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial. Am J Transplant 2010; 10: 1385-1393.
21. Denning DW, Griffiths CE,. Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole. Clin Exp Dermatol 2001; 26: 648-653. (Pubitemid 33070418)
22. Cowen EW, Nguyen JC, Miller DD, et al,. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol 2010; 62: 31-37.
23. Miller DD, Cowen EW, Nguyen JC, McCalmont TH, Fox LP,. Melanoma associated with long-term voriconazole therapy: A new manifestation of chronic photosensitivity. Arch Dermatol 2010; 146: 300-304.
24. Rubenstein M, Levy ML, Metry D,. Voriconazole-induced retinoid-like photosensitivity in children. Pediatr Dermatol 2004; 21: 675-678. (Pubitemid 39657395)
25. Frisch S, Askari SK, Beaty SR, Burkemper CN,. X-linked chronic granulomatous disease with voriconazole-induced photosensitivity/ photoaging reaction. J Drugs Dermatol 2010; 9: 562-564.
26. Racette AJ, Roenigk HH Jr,., Hansen R, Mendelson D, Park A,. Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl. J Am Acad Dermatol 2005; 52 (Suppl 1): S81-S85.
27. Epaulard O, Saint-Raymond C, Villier C, et al,. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients. Clin Microbiol Infect 2010; 16: 1362-1364.
28. Ibrahim SF, Singer JP, Arron ST,. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole. Dermatol Surg 2010; 36: 1752-1755.
29. Vadnerkar A, Nguyen MH, Mitsani D, et al,. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients. J Heart Lung Transplant 2010; 29: 1240-1244.
30. Zwald FO, Christenson LJ, Billingsley EM, et al,. Melanoma in solid organ transplant recipients. Am J Transplant 2010; 10: 1297-1304.
31. Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF,. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Cancer 2009; 115: 2523-2530.
32. Colegio OR, Proby CM, Bordeaux JS, McGregor JM,. Prognosis of pretransplant melanoma. Am J Transplant 2009; 9: 862.
33. Arron ST, Jennings L, Nindl I, et al,. Viral oncogenesis and its role in nonmelanoma skin cancer. Br J Dermatol 2011; 1664: 1201-1213.